Clinical Trial Update: Statins in Proteinuric Nephropathies [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating statins for proteinuric nephropathies has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Hypertension
• Proteinuria

Drugs mentioned

• Statin (statin)

Snippet

Sponsor: Mario Negri Institute for Pharmacological Research | Conditions: Chronic Nephropathy, Proteinuria | Phase 3 | Status: COMPLETED